Trading

Data

Solutions

Insights

Sight Sciences Stock

sightsciences.comHealthcareFounded: 2010Funding to Date: $180MM

Sight Sciences is a medical devices company developing products that target the underlying causes of the world's most prevalent eye diseases.

Learn more about Sight Sciences IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for Sight Sciences.

Register Today

Team

Management Team

Jesse Selnick

Chief Financial Officer

Shawn O'Neil

Chief Commercial Officer

Paul Badawi

Co-Founder, President, Chief Executive Officer & Board Member

David Badawi MD

Co-Founder, Chief Technology Officer & Board Member

Reay Brown

Chief Medical Officer

Board Members

David Badawi MD

Valeska Schroeder Ph.D

Mack Hicks

Hicks Equity Partners

Paul Badawi

Carter Meyer JD

Scientific Health Development

Tommy Hicks

Other companies like Sight Sciences in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Sector

Sector

Last Round Est. Valuation

$3.67B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

Sector

Sector

Last Round Est. Valuation

$1.08B

Cytonics

Sector

Healthcare

Precision Neuroscience

Sector

Healthcare

News

Eyewire Today 12/09/2019

Sight Sciences Appoints Erica Rogers to its Board of Directors

Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepr

FinSMEs 09/05/2019

Sight Sciences Raises $56M in Funding | FinSMEs

Sight Sciences, a medical device company focused on ophthalmology and optometry, glaucoma and dry eye disease, closed a $31m in Series D financing

Popular Topics

Popular Topics

Sight Sciences Stock

Register for Details